Get the Stockscreener App
2.00
1.96%
-0.04
Gossamer Bio Inc stock is traded at $2.00, with a volume of 2.68M.
It is down -1.96% in the last 24 hours and up +60.00% over the past month.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
See More
Previous Close:
$2.04
Open:
$2
24h Volume:
2.68M
Relative Volume:
1.20
Market Cap:
$454.60M
Revenue:
-
Net Income/Loss:
$-179.82M
P/E Ratio:
-1.5038
EPS:
-1.33
Net Cash Flow:
$-159.16M
1W Performance:
+8.70%
1M Performance:
+60.00%
6M Performance:
+101.29%
1Y Performance:
+127.27%
1-Day Range:
$1.91
$2.035
1-Week Range:
$1.84
$2.18
52-Week Range:
$0.6617
$2.18
Gossamer Bio Inc Stock (GOSS) Company Profile
Name
Gossamer Bio Inc
Sector
Industry
Phone
(858) 684-1300
Address
3115 MERRYFIELD ROW, SAN DIEGO, CA
Compare GOSS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GOSS
Gossamer Bio Inc
|
2.00 | 463.70M | 0 | -179.82M | -159.16M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-14-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-25-24 | Initiated | Oppenheimer | Outperform |
| Apr-05-24 | Resumed | Wedbush | Outperform |
| Jul-27-23 | Downgrade | UBS | Buy → Neutral |
| Mar-07-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-01-23 | Initiated | Guggenheim | Neutral |
| Dec-07-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-07-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-07-22 | Downgrade | SMBC Nikko | Outperform → Neutral |
| Oct-20-22 | Initiated | Goldman | Buy |
| Sep-21-22 | Initiated | JP Morgan | Neutral |
| Sep-19-22 | Initiated | Wedbush | Outperform |
| Apr-18-22 | Initiated | Raymond James | Outperform |
| Apr-06-22 | Initiated | UBS | Buy |
| Jan-10-22 | Upgrade | SMBC Nikko | Neutral → Outperform |
| Nov-09-21 | Resumed | Cantor Fitzgerald | Overweight |
| Sep-21-21 | Resumed | Piper Sandler | Overweight |
| Jun-29-20 | Initiated | H.C. Wainwright | Buy |
| Apr-22-20 | Initiated | Piper Sandler | Overweight |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Dec-03-19 | Resumed | BofA/Merrill | Buy |
| Oct-30-19 | Initiated | Berenberg | Buy |
| Mar-05-19 | Initiated | Barclays | Overweight |
| Mar-05-19 | Initiated | BofA/Merrill | Buy |
| Mar-05-19 | Initiated | Evercore ISI | Outperform |
| Mar-05-19 | Initiated | SVB Leerink | Outperform |
View All
Gossamer Bio Inc Stock (GOSS) Latest News
Will Gossamer Bio Inc. price bounce be sustainableFree Technical Entry Strategy for Beginners - Newser
Real time scanner hits for Gossamer Bio Inc. explainedAsset Allocation Summary With Future Outlook - Newser
Institutional scanner results for Gossamer Bio Inc.Free Smart Trade Plans With Risk Protection - Newser
Regression analysis insights on Gossamer Bio Inc. performanceFree Weekly Top Gainers Forecast Watchlist - Newser
Why Gossamer Bio Inc. is moving todayWeekly Price Target Forecast and Alerts - Newser
Is Gossamer Bio Inc. forming a reversal patternFree Technical Entry Strategy for Beginners - Newser
When is Gossamer Bio Inc. stock expected to show significant growthSmart Portfolio Entry Points With Low Risk - jammulinksnews.com
What catalysts could drive Gossamer Bio Inc. stock higher in 2025Financial News Trend Scanner For Every Investor - jammulinksnews.com
Institutional Investors Have a Lot Riding on Gossamer Bio, Inc. (NASDAQ:GOSS) With 63% Ownership - 富途牛牛
Can Gossamer Bio Inc. rally from current levelsDaily Stock Movement Forecast with Accuracy - Newser
Why Gossamer Bio Inc. stock attracts strong analyst attentionFree Conservative Entry for High Return Setup - Newser
Custom strategy builders for tracking Gossamer Bio Inc.Safe and Scalable Return Strategy Blueprint - Newser
What momentum shifts mean for Gossamer Bio Inc.Stock Price Prediction Using AI Tools - Newser
Scotiabank Initiates Outperform on Gossamer Bio (GOSS) with an $11 PT, Highlights Potential of PAH Drug Seralutinib - Insider Monkey
Multi asset correlation models including Gossamer Bio Inc.Free Confirmed Setup With Expert Accuracy - Newser
How Gossamer Bio Inc. stock performs during market volatilityBuy Zone Strategy with Pattern Recognition - Newser
Is this a good reentry point in Gossamer Bio Inc.AI Powered Stock Trend Prediction Model - Newser
What makes Gossamer Bio Inc. stock price move sharplyShort Term Gain Strategy with AI Logic - Newser
Is Gossamer Bio Inc. stock poised for growthExit Strategy Guide With Risk Control Plan - Newser
Custom Dashboard Highlights Gossamer Bio Inc. Price MomentumConservative Entry for High Return Setup Backed - beatles.ru
Reversal indicators forming on Gossamer Bio Inc. stockMachine Learning Stock Price Forecast Tool - Newser
Investors Buy Large Volume of Call Options on Gossamer Bio (NASDAQ:GOSS) - Defense World
Heatmap Data Shows High Activity in Gossamer Bio Inc. SectorDaily Chart Pattern Stock Forecast Shows Bullish Setup - metal.it
Gossamer Bio Inc.’s Price Action Aligns with Quant SignalsBuy Signal Based on Chart Analysis Confirmed - metal.it
Technical Bounce Expected in Gossamer Bio Inc. Next WeekBreakout Momentum Picks With Protection Outlined - metal.it
Gossamer Bio Inc (GOSS) Stock: A Year of Declines and Increases - investchronicle.com
Is Gossamer Bio Inc. a Top Dividend Stock to Watch in 2025Portfolio Building Plan and Summary Guide - Newser
What institutional investors are buying Gossamer Bio Inc. stockBest Dividend Picks For 2025 - jammulinksnews.com
Is it the right time to buy Gossamer Bio Inc. stockAdvanced Screener Ideas For Every Investor - jammulinksnews.com
How strong is Gossamer Bio Inc. company’s balance sheetInvest confidently with daily market forecasts - jammulinksnews.com
What is the dividend policy of Gossamer Bio Inc. stockFree Stock Market Trend Analysis - jammulinksnews.com
What are the latest earnings results for Gossamer Bio Inc.Market Forecast Tracker For Smart Trading - jammulinksnews.com
Multi asset correlation models including Gossamer Bio Inc. Free Smart Allocation Stock Pick Insights - Newser
Why is Gossamer Bio Inc. stock attracting strong analyst attentionNavigate market shifts with confidence - jammulinksnews.com
Gossamer Bio Inc Stock (GOSS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):